Stock Report

Emcure Pharmaceuticals Ltd Q4 FY2026 consolidated profit up at Rs. 243.40 crores

Posted On : 2026-05-05 21:13:51( TIMEZONE : IST )

Emcure Pharmaceuticals Limited has reported Consolidated financial results for the period ended March 31, 2026.

Financial Results (Q4 FY2026) - QoQ Comparison

The company has reported total income of Rs. 2473.695 crores during the period ended March 31, 2026 as compared to Rs. 2365.331 crores during the period ended December 31, 2025.

The company has posted net profit / (loss) of Rs. 243.403 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 230.541 crores for the period ended December 31, 2025.

The company has reported EPS of Rs. 12.84 for the period ended March 31, 2026 as compared to Rs. 12.16 for the period ended December 31, 2025.

Financials	Q4 FY2026	Q3 FY2026	% Change
Total Income	₹ 2473.695 crs	₹2365.331 crs	4.58%
Net Profit	₹243.403 crs	₹230.541 crs	5.58%
EPS	₹12.84	₹12.16	5.59%

Financial Results (Q4 FY2026) - YoY Comparison

The company has reported total income of Rs. 2473.695 crores during the period ended March 31, 2026 as compared to Rs.2120.698 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs.243.403 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.188.957 crores for the period ended March 31, 2025.

The company has reported EPS of Rs.12.84 for the period ended March 31, 2026 as compared to Rs.9.97 for the period ended March 31, 2025.

Financials	Q4 FY2026	Q4 FY2025	% Change
Total Income	₹ 2473.695 crs	₹2120.698 crs	16.65%
Net Profit	₹243.403 crs	₹188.957 crs	28.81%
EPS	₹12.84	₹9.97	28.79%

Financial Results (Year Ended FY2026) - YoY Comparison

The company has reported total income of Rs.9216.204 crores during the Financial Year ended March 31, 2026 as compared to Rs.7963.258 crores during the Financial Year ended March 31, 2025.

The company has posted net profit / (loss) of Rs.924.361 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.681.332 crores for the Financial Year ended March 31, 2025.

The company has reported EPS of Rs.48.77 for the Financial Year ended March 31, 2026 as compared to Rs.36.43 for the Financial Year ended March 31, 2025.

Financials	Year Ended FY2026	Year Ended FY2025	% Change
Total Income	₹9216.204 crs	₹7963.258 crs	15.73%
Net Profit	₹924.361 crs	₹681.332 crs	35.67%
EPS	₹48.77	₹36.43	33.87%

Shares of Emcure Pharmaceuticals Limited was last trading in BSE at Rs. 1691.45 as compared to the previous close of Rs. 1785.15. The total number of shares traded during the day was 24078 in over 3130 trades.

The stock hit an intraday high of Rs. 1830.35 and intraday low of 1677.00. The net turnover during the day was Rs. 41864288.00.